News

News

Friday, 06 September 2019 14:46

Next stop: EBBS 2019 in Prague!

The 2019 48TH Meeting of the European Brain and Behaviour Society will be held on 21-24 September 2019 in Prague, Czech Republic. 

The Meeting expects to attract more than 600 scientists and will constitute a very important international scientific event for European Neuroscience. Researchers will have the unique opportunity to discuss latest research and development issues and experiences on different aspects of Neuroscience. The EBBS Meeting will focus on the relationships between brain and behaviour in health and disease. An exciting program has been prepared featuring the most prominent scientists in the field.

Saturday, 27 July 2019 04:56

2019 European Pain School, a well tested partnership!

It was a big pleasure spending again some time at the European Pain School in Siena, discussing on our common passion, Pain Research, from the different angles, research/clinic and industry/manufacturing.

Tuesday, 11 June 2019 09:18

NEWS for our Brazilian customers

We are glad to welcome UGO BASILE Brasil in the Ugo Basile family!

At UB-BR, a team of enthusiastic  sales people is ready to take care of our customers in Brazil, in close cooperation with the sales team at our Italian headquarters!

logo UB BR

 

Monday, 13 May 2019 09:16

NEWS for our Australian & NZ customers

We are glad to welcome APAC SCIENTIFIC Pty Ltd. in the Ugo Basile family!

At APAC, a team of enthusiastic and knowledgeable sales people is ready to take care of our customers in AU & New Zealand, in close cooperation with the sales team at our Italian headquarters!

apac ub

 

Wednesday, 17 April 2019 15:16

Next stop: NEUPSIG 2019 in London!

The NeuPSIG 2019, International Congress on Neuropathic Pain (NeuPSIG 2019) is an international forum that provides the latest research and developments in understanding the mechanisms, assessment, prevention and treatment of neuropathic pain. This meeting is an excellent opportunity to network and strengthen scientific collaboration. We hope you will join us in this unique opportunity to meet colleagues from a wide range of disciplines, countries and backgrounds, disseminating and learning about the latest developments in the field. 

This year's International Congress on Neuropathic Pain will be held in London, UK at the London Metropole Hotel. All conference programming will take place inside the hotel.

Friday, 06 September 2019 14:46

We're exhibiting at the AD/PD 2019, in Lisbon

The AD/PDTM 2019, the 14th​ International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders, will build on the well-earned reputation of previous AD/PDTM Conferences. The ground breaking series of Alzheimer's and Parkinson's Diseases Conferences attract international medical and scientific professionals worldwide.​​

The Conference is at the forefront of unraveling the mechanisms and improving the treatment of Alzheimer's, Parkinson's and other related neurodegenerative diseases. AD/PDTM Conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease, prevention and therapy.

The forthcoming AD/PDTM meeting, in 2019 will take place in Lisbon, Portugal, one of the most classical cities in Europe. 

Wednesday, 06 March 2019 15:06

We're exhibiting at the 13th Meeting of the German Neuroscience Society

Like every second year, the GERMAN NEUROSCIENCE SOCIETY will gather in Göttingen from March 20th to 23rd, 2019 for its biennial meeting.

Wednesday, 06 February 2019 16:30

Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain. A recent publication

Chun Yang, Xi Fang and their collaborators at Tongji Medical College, Wuhan, China, Soochow Univrsity, Changzhou, China, and Chiba University, Chiba, Japan, recently published an interesting paper on TRANSLATIONAL PSYCHIATRY, discussing the role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain,

Results about mechanical withdrawal test were obtained via Ugo Basile's Electronic VonFrey eVF.

38450 002 with glass prism 654x768  DSC 0100 1024x679

Abstract

“Patients with chronic neuropathic pain frequently suffer from symptoms of anhedonia, which is a core symptom of depression. Accumulating studies suggest that gut microbiota may play a role in depression via gut–microbiota–brain axis. However, it is unknown whether gut microbiota plays a role in neuropathic pain-associated anhedonia. Here, we used a rat model of spared nerve injury (SNI). Hierarchical cluster analysis of sucrose preference test (SPT) results was used to classify the SNI rats with or without anhedonia-like phenotype. The 16S ribosomal RNA sequencing analysis showed abnormal composition of gut microbiota in the anhedonia susceptible compared to sham-operated rats and resilient rats. Furthermore, antibiotics-treated mice showed pain as well as depression-like and anhedonia-like phenotypes, suggesting a role of gut microbiota in these abnormal behaviors. Transplantation of fecal microbiota from anhedonia susceptible rats into antibiotics-treated pseudo-germ-free mice significantly exaggerated pain and depression-like phenotypes, including anhedonia. In contrast, transplantation of fecal microbiota from resilient rats into antibiotics-treated pseudo-germ-free mice significantly improved pain and depression-like phenotypes, including anhedonia. In conclusion, this study suggests that abnormal composition of gut microbiota may contribute to anhedonia susceptibility post SNI surgery, and that gut microbiota also plays a role in the pain as well as depression-like phenotypes. Interestingly, fecal microbiota transplantation from SNI rats with or without anhedonia can alter pain, depression-like and anhedonia-like phenotypes in the pseudo-germ-free mice. Therefore, it is likely that gut microbiota plays a key role in the pain as well as depression-like phenotypes including anhedonia in rodents with neuropathic pain.

Read the complete paper at the following link: https://www.nature.com/articles/s41398-019-0379-8

paper evf

 

 

Page 1 of 3

P.IVA, C.F. e n. Registro Imprese di Varese 02728350121 - n. REA VA-281472 - Cap. soc. i.v. € 165.000,00